Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Crohn's Disease Treatment Market, by Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators & Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacy and e-Commerce), and by Region - Global Forecast to 2026

Published Date : May 2018

Crohn’s Disease Treatment Market – Global Insights Crohn’s disease is a form of inflammatory bowel disease (IBD) that refers to a chronic inflammatory condition of the gastrointestinal tract

Coherent Market Insights
U.S. Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A and Influenza Virus Type B) and by Age Group (Pediatrics and Adults) - Trends, and Forecast till 2025

Published Date : Dec 2017

U.S. Influenza Vaccines Market– Prevention of Virus through Vaccination Aids in Reducing Burden of the Disease Influenza is an infection caused by influenza virus and is commonly known as flu. Vaccinati

Coherent Market Insights
Global Enteral Nutrition Market, by Disease Type (Standard and Chronic), by Age Group (Below 15, 15 to 30, 30 to 45, 45 to 60, and Above 60), by End-use Industry (Hospitals, Clinics, and Long Term Care Facilities), by and Geography - Trends, and Forecast to 2025

Published Date : Dec 2017

Global Enteral Nutrition Market - Insights Enteral nutrition, also known as tube feeding refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including no

Coherent Market Insights
Middle East Tapentadol Market, by Therapeutic Application (Pain Management (Neuropathic Pain, Cancer Pain, and Others), and Cough Treatment), and by Countries - Trends and Forecast to 2025

Published Date : Nov 2017

Tapentadol - Become Pain Free! Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative

Coherent Market Insights
U.S. Opioids Market, By Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment) and by Geography - Trends and Forecast to 2025

Published Date : Nov 2017

Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromo

Coherent Market Insights
Global Medical Adhesives and Sealants Market, by Product Type (Synthetic and Natural), by Application (Internal, External and Dental), by End-use Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Dental Clinics, and Others) and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Medical Adhesives and Sealants Market – Providing Adhesive Solutions Post Surgeries Medical adhesives and sealants are commonly employed in medical practices for appliance bonding and surgical procedure

Coherent Market Insights
Global Clinical Nutrition Market by Product Type (Infant Nutrition (Milk based, soy-based, Organic, Probiotics/ Prebiotics and Others), Enteral Nutrition (Standard Nutrition, Disease Specific) Parenteral Nutrition (Amino acids, Fats and Carbohydrates), and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Clinical Nutrition – The New Tradition is Good Nutrition Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vit

Coherent Market Insights
Chagas Disease Treatment Market, Product Type (Benznidazole, and Nifurtimox), Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) and by Region - Global Industry Insights, and Forecast till 2025

Published Date : May 2018

Chagas Disease Treatment Market - Insights Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-suck

Coherent Market Insights
Anti-epileptic Drugs for Pediatrics Market by Drug Type (1st generation, 2nd generation, and 3rd generation), and Region - Global Industry Insights, Trends, and Forecast, 2017-25

Published Date : Sep 2017

Anti-Epileptic Drugs for Pediatrics Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of the brain obstructed by se

Coherent Market Insights
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Lenalidomide, Decitabine, Deferasirox), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025

Published Date : Sep 2017

Myelodysplastic Syndrome Treatment Market Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells call

Coherent Market Insights
Global Gunshot Injuries Treatment Market, By Product (XStat, Airwrap, Floseal), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Gunshot Injuries Treatment Market: Life Saviors at the Battlefield Gunshot injury, also referred to as ballistic trauma, is a form of physical trauma caused when a bullet, knife or any sharp projectile is sho

Coherent Market Insights
Global Epistaxis Market, By Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Epistaxis - A Common Clinical Condition Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive

Coherent Market Insights
Poly Adenosine Diphosphate Ribose Polymerase Market, by Drug (Olaparib, Rucaparib, Niraparib, and Others), by Cancer Type (Prostate Cancer, Ovarian Cancer, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Oct 2019

Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as e

Coherent Market Insights
Lymphocyte Activation Gene - 3 Protein Market, by Drug (BMS-986016 (Relatlimab), IMP321, IMP701, MGD013, and Others), by Cancer Type (Breast Cancer, Melanoma, Solid Tumors, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Oct 2019

Immune checkpoint receptors such as lymphocyte activation gene - 3 (LAG-3) protein are found on cell surface of effector T cells and regulatory T cells (Tregs). T cells are a type of white blood cells that eliminate unhealthy or foreign cells that enter the immune sys

Coherent Market Insights
Testosterone Replacement Therapy Market, by Route of Administration (Injectables, Parenteral), by Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate) and by Geography -Size, Share, Outlook, and Opportunity Analysis 2018 –2026

To Be Published : Oct 2019

Testosterone Replacement Therapy (TRT) or low testosterone therapy is commonly called hormone therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is clinical syndrome, which results in the failure

Coherent Market Insights
Periodontal Disease Therapeutics Market by Drug Type (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, Periochip, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online) - Size, Share, Outlooks, and Opportunity Analysis 2018 - 2026

To Be Published : Oct 2019

Periodontitis is a chronic bacterial infection caused by microbial plaque often known as gum disease that is colonized on tooth surface and below the gingival margin. It involves progressive loss of the alveolar bone, which is a thickened ridge of bone that contains t

Coherent Market Insights
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market, by Disease Management (Nutritional Management and Pancreatic Enzyme Replacement Therapy (PERT)), by Therapeutic Drugs (Creon, Zenpep, Pancreaze, Ultresa, Viokace, and Others), and by Geography (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018–2026

To Be Published : Oct 2019

Exocrine pancreatic insufficiency (EPI) is a condition associated with deficiency of exocrine pancreatic enzymes that results in the inability to digest food or maldigestion. EPI may be associated with certain diseases and conditions that affect the pancreas such as c

Coherent Market Insights
Antithrombin Market, By Application (Therapeutics, Research, and Diagnostics), By Source (Human, Goat Milk, and Others), By Dosage Form (Lyophilized and Liquid), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

To Be Published : Oct 2019

Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency

Coherent Market Insights
Nasopharyngeal Carcinoma Treatment Market, By Drug (Ellence, Taxotere, Bleomycin, and Methotrexate), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook and Opportunity Analysis 2018–2026

To Be Published : Oct 2019

Nasopharyngeal carcinoma is a rare cancer, affecting the part of throat connecting nose and mouth, known as pharynx. Nasopharyngeal carcinoma are of three types, based on cell appearance under microscope. These include keratinizing squamous cell carcinoma, non- kerati

Coherent Market Insights
Overactive Bladder Treatment Market by Drug Type (Anticholinergics (Oxybutynin, Darifenacin, Fesoterodine, Solifenacin, Tolterodine, and Trospium), Mirabegron, and Botox), by Route of Administration (Topical, Oral, and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Size, Share, Outlook and Opportunity Analysis 2018 - 2026

To Be Published : Oct 2019

Overactive bladder is a common medical condition where there is sudden urge of urination. Overactive bladder is sometimes coupled with urine leakage, condition known as incontinence. Millions of people across the globe suffers from overactive bladder and it is more co

Coherent Market Insights
Peptide Therapeutics in Metabolic Disorders Market, By Route of Administration (Intravenous, Oral, Nasal, and Others), By Synthesis Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, and Hybrid Technology), and By Distribution Channels (Hospitals, Specialty Clinics, Retail Pharmacy, and Online Pharmacy) - Size, Share, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Oct 2019

Peptide therapeutics, due to their various advantages such as high stability, selectivity, safety, efficacy, bioavailability, and tolerability offers wide applications over the other therapeutics classes. Over 7,000 naturally occurring peptides have been identified, w

Coherent Market Insights
Pharyngitis Therapeutics Market, by Source of Infection (Viral and Bacterial), By Drug Class (Antiviral Drugs, Antibacterial Drugs, Anti-inflammatory Drugs, and Topical Anesthetics Drugs), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Geography - Size, Share, Outlook, and Opportunity Analysis, 2018–2026

To Be Published : Oct 2019

Pharyngitis, commonly referred to as sore throat, causes inflammation of pharynx located behind the throat. Pharyngitis is caused by bacterial or viral infections and cases of pharyngitis are majorly observed in colder months of the year. Measles, adenovirus, chickenp

Coherent Market Insights
Scar Treatment Market, by Product Type (Topical Products (Gels, Creams, Silicone Sheets, and Others), Laser Products (Pulse-dyed laser, CO2 Laser, and others), Injectable, and Others), by Scar Type (Atrophic Scar, Hypertrophic Scar, Keloid Scar, Contracture Scar, and Others), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Oct 2019

Any burn, injury or trauma such as surgeries can cause a scar on the skin. Scarring is a natural healing process, which occurs after an injury. Its appearance and treatment depends on multiple factors such as the depth and size of the wound or the cut. It also depends

Coherent Market Insights
Cordyceps Sinensis Extract Market, by Dosage Form (Powder, Tablet, and Capsule), by Application (Dietary Supplement, Medicinal Use, and Others) by Distribution Channel (Retail Pharmacy and Online Pharmacy), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Oct 2019

Cordyceps Sinensis also called as ophiocordyceps sinensis is combination of parasitic fungus species and dead caterpillars that offer several potential health applications. It has been in use in traditional Chinese and Tibetan medicines as remedy for around 21 ailment

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.